Gary Ansel (Columbus, USA) gives Vascular News a summary from VLF 2019 on the main points that were covered at the forum organised by the VIVA physicians. Key takeaways included “a lot more” information on paclitaxel and examining the...
The BEST-CLI trial in the USA is set to continue, while the SWEDEPAD trials from (and BASIL-3 in the UK) have paused enrolment in light of the data from Katsanos et al meta-analysis that was published in JAHA in 2018. Vascular News spoke to Matthew...
Krishna Rocha-Singh (Springfield, USA) tells Vascular News that plans after VLF 2019 include publishing a white paper and expeditiously pooling individual patient-level data from the industry randomised controlled trials for independent statistical...
